References
- American Diabetes Association. The physician's guide to type II diabetes: diagnosis and treatment. Alexandria. VA: Am Diabetes Assn. 1984
- Kolterman OG, Gray RS, Shapiro G, et al. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 1984:33(4): 346–54
- Wahlin-Boll E, Melander A, Sartor G, et al. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol 1980: 18(3): 279–83
- Skillman TO, Feldman JM. The pharmacology of sulfonylureas. Am J Med 1981: 70(2): 361–72
- Feldman JM. Review of glyburide after one year on the market. Am J Med 1985: 79(Suppl 3B): 102–8
- Prendergast BD. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. Clin Pharm 1984:3(5): 473–85
- Weissman PN, Shenkman L, Gregerman RL Chlorpropamide hyponatremia: drug-induced inappropriate antidiuretic-hormone activity. N Engl J Med 1971: 284(2): 65–71
- Gerich J. Sulfonylureas in the treatment of diabetes mellitus—1985. Mayo Clin Proc 1985: 60(7): 439–43
- University Group Diabetes Program. A study of the effects of hypoglycemic agents and vascular complications with adult onset diabetes, II. Mortality results. Diabetes 1970: 19(10): 789–830
- Kilo C. Miller JP, Williamson JR. The crux of the UGDP: spurious results and biologically inappropriate data analysis. Diabetologia 1980: 18(3): 179–85
- Mazur M. A drug by any other name. Diabetes Forecast 1986: 39(Sep): 39–41
- Osci K, O'Dorlsio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes: effects on glucoregulation and lipid metabolism. Am J Med 1984: 77(6): 1002–9